Whilst the use of DPP-4 inhibitors may theoretically support weight loss in the treatment of obesity through increasing the half-life of endogenous GLP-1, weight loss associated with their use is clinically insignificant (0.160.64 kg) [29], and as such their use in obesity is not explored further in this manuscript
Low blood glucose levels (hypoglycemia), including severe hypoglycemia, may occur if this medicine is used with an insulin secretagogue or insulin
Yes, vegans and vegetarians can benefit from both compounds, even more so than people who regularly consume animal products
Oxidative stress: what is it
Success with GLP-1s requires taking it daily (pills) or weekly (injections), managing side effects, and maintaining the habit through months of gradual progress
Depending on how long an injection pen or semaglutide vial is left out of the fridge, you may have to toss it and use a new one